Haemonetics Corporation (HAE)

Last Closing Price: 94.80 (2024-05-16)

Weighted-Average Shares Outstanding (Basic) (Annual)

Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.

Haemonetics Corporation (HAE) had Weighted-Average Shares Outstanding (Basic) of 50.78M for the most recently reported fiscal year, ending 2023-03-31.

Figures for fiscal year ending 2023-03-31
Income Statement Financials
$1.17B
$115.40M
$553.56M
$615.10M
$1.01B
$156.03M
$-14.63M
$141.40M
$141.40M
$115.40M
$115.40M
$115.40M
$115.40M
$156.03M
$251.31M
Weighted-Average Shares Outstanding (Basic)
50.78M
51.42M
$2.27
$2.24
Balance Sheet Financials
$769.72M
$310.88M
$1.17B
$1.93B
$251.82M
$754.10M
$865.01M
$1.12B
$818.00M
$76.00M
$818.00M
50.45M
Cash Flow Statement Financials
$273.06M
$-143.79M
$-100.36M
$259.50M
$284.47M
$24.97M
$25.58M
--
--
Fundamental Metrics & Ratios
3.06
--
--
0.48
0.94
52.63%
13.35%
13.35%
21.50%
12.10%
9.87%
$164.47M
--
--
--
0.60
2.13
6.52
55.95
14.11%
151.85%
5.96%
7.34%
$16.21
$3.20
$5.31